An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer.

Autor: Fleischer, Thomas, Haugen, Mads Haugland, Ankill, Jørgen, Silwal‐Pandit, Laxmi, Børresen‐Dale, Anne‐Lise, Hedenfalk, Ingrid, Hatschek, Thomas, Tost, Jörg, Engebraaten, Olav, Kristensen, Vessela N.
Zdroj: Molecular Oncology; Aug2024, Vol. 18 Issue 8, p2042-2059, 18p
Databáze: Complementary Index
Externí odkaz: